Login

The Investor on Tour - Q&A with Francis Van Eeckhout, CEO Deceuninck | Francis Van Eeckhout - CEO of Deceuninck 00:10:00

Share On Facebook Share On Twitter

Francis Van Eeckhout is Chairman/Interim CEO at Deceuninck.

Recent Videos

00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences

Suggestions

00:10:00
Dome Mountain Project Overview: Near-Production Gold Mine with Significant Blue Sky Potential
00:10:00
Revolutionizing Urban Mobility: A Vision for Sustainable Transportation Solutions | Brian Dalton , CEO, Altius Minerals Corp.
00:10:00
Unlocking the Power of Your Stimulus Check: Step 4 of 5 Vital Financial Moves | Wakefield Hare - Financial Planner, Greater Than Financial
00:10:00
Castlepoint Employee Spotlight: Kian Rahmanzadeh
00:10:00
Sanjiv Kumar Singh, Director (Mining) at Hindustan Copper Limited, oversees mining operations and strategy for the company.|Shri Ghanshyam Sharma at Hindustan Copper Limited
00:10:00
Tim Chen, CEO of NerdWallet, appears on 'Closing Bell Overtime' to discuss the company's new credit-building card, a significant stock surge, and more.|Tim Chen is the founder and CEO of NerdWallet.
00:10:00
Aeris Resources: Transforming with Strong Copper Production and Exploration Focus
00:10:00
Care deeply about the next generation of local entrepreneurs.|Ari Newman,Partner, The Fund Rockies,The Fund
00:10:00
Committed to advancing transformative therapies for people with cancer and rare diseases|MICHAEL SOLOMON,Director,Proteon Pharmaceuticals
00:10:00
Investment Principles & Capital Allocation Framework with Lakshay Behl, Founder of Behl Capital | Westernston Inc.
00:10:00
Evolution Energy Minerals Presents the Chalalo Graphite Project: High-Grade, Low-Capex Development Strategy in Tanzania
00:10:00
Gene Sheridan, CEO of Navitas Semiconductor, discusses the company's earnings beat, revenue growth expectations, and advancements in artificial intelligence.|Gene Sheridan, CEO of Navitas Semiconductor

© 2017 - Neuhu+